13F

Stock

Alnylam Pharmaceuticals, Inc.

ALNY · held by 15 managers

Reported value

$628M

Holders

15

+0 new · −0 exited

Holders’ est. mark

−$100K

Price effect on 9 books still in the name

Largest holder

$576.8M

NORGES BANK

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
NORGES BANK2.14M$576.8MHeld
BARCLAYS PLC2.43M$28.5M−$2.4MAdded$2.02M
DANSKE BANK A/S53.2K$14.4M$1.85MCut−$225.9K
OP Asset Management Ltd13.7K$3.69MHeld
Swiss Life Asset Management Ltd9.81K$2.65M$342.4KCut−$363.9K
Sanctuary Advisors, LLC3.29K$888.4KHeld
ONTARIO TEACHERS PENSION PLAN BOARD1.34K$363.2K$46.7KCut−$848
Marex Group plc1.17K$316.7K$40.7KAdded$18.4K
INDEPENDENT FINANCIAL GROUP, LLC890$240.3KHeld
Prestige Wealth Management Group LLC316$85.3K$11KAdded$11K
Evelyn Partners Investment Management LLP250$67.5K$8.68KAdded$8.68K
VIRTUS ADVISERS, LLC47K$54.1KHeld
Leonteq Securities AG32$9.07K$1.54KCut−$25.5K
Aventura Private Wealth, LLC30$8.1K$1.04KAdded$1.04K

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.